Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $879.34 | 52 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $251.14 | 16 | $0 (2019) |
| ABBVIE INC. | $176.92 | 9 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $40.24 | 2 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $31.72 | 2 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $31.49 | 2 | $0 (2020) |
| Organogenesis Inc. | $30.88 | 1 | $0 (2024) |
| Kaleo, Inc. | $30.35 | 2 | $0 (2019) |
| Amgen Inc. | $29.87 | 2 | $0 (2022) |
| Abbott Laboratories | $26.27 | 2 | $0 (2022) |
| Sanofi Pasteur Inc. | $21.51 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $97.24 | 5 | Organogenesis Inc. ($30.88) |
| 2023 | $134.28 | 7 | AbbVie Inc. ($88.01) |
| 2022 | $122.93 | 7 | ABBVIE INC. ($59.84) |
| 2021 | $33.55 | 2 | Amarin Pharma Inc. ($17.53) |
| 2020 | $80.63 | 5 | Takeda Pharmaceuticals U.S.A., Inc. ($31.72) |
| 2019 | $85.73 | 6 | Shire North American Group Inc ($55.60) |
| 2018 | $173.11 | 11 | Shire North American Group Inc ($110.66) |
| 2017 | $151.87 | 9 | Shire North American Group Inc ($84.88) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 2 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/04/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2019 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2019 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2019 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: NEUROSCIENCE | ||||||
| 04/29/2019 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Sleep | ||||||
| 03/25/2019 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: NEUROSCIENCE | ||||||
| 01/29/2019 | Kaleo, Inc. | EVZIO (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: OPIOID ANTAGONIST | ||||||
| 12/15/2018 | Abbott Laboratories | FreeStyle Libre blood glucose Flash Monitoring System (Device) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: Diabetes Care | ||||||
| 11/28/2018 | Otsuka America Pharmaceutical, Inc. | BREATHTEK (Device) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2018 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2018 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: NEUROSCIENCE | ||||||
| 07/03/2018 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2018 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: NEUROSCIENCE | ||||||
| 03/26/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2018 | Kaleo, Inc. | Evzio (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Opioid Antagonist | ||||||
| 03/14/2018 | Sanofi Pasteur Inc. | PENTACEL (Drug), FLUZONE HIGH-DOSE, ADACEL | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: VACCINES | ||||||
| 02/13/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2017 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2017 | Roche Diagnostics Corporation | POC cobas Liat Analyzer, Assays, Controls and Accessories (Device) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: Point of Care | ||||||
| 10/10/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/26/2017 | Orexigen Therapeutics, Inc. | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: OBESITY | ||||||
| 09/20/2017 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2017 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2017 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 745 | 972 | $76,092 | $34,733 |
| 2022 | 16 | 740 | 979 | $76,922 | $33,883 |
| 2021 | 17 | 794 | 1,100 | $82,643 | $36,846 |
| 2020 | 22 | 1,203 | 1,618 | $118,532 | $48,612 |
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2022 | 28 | 28 | $1,092 | $535.08 | 49.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 25 | 26 | $936.00 | $431.36 | 46.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 11 | 11 | $209.00 | $204.82 | 98.0% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2022 | 12 | 12 | $432.00 | $200.56 | 46.4% |
| 82043 | Urine microalbumin (protein) level | Office | 2022 | 21 | 34 | $447.00 | $194.00 | 43.4% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2022 | 18 | 18 | $342.00 | $160.56 | 46.9% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2022 | 22 | 24 | $288.00 | $153.29 | 53.2% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 17 | 22 | $198.00 | $113.06 | 57.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 110 | 177 | $36,629 | $13,825 | 37.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 74 | 74 | $15,200 | $9,450 | 62.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 66 | 108 | $15,648 | $6,198 | 39.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 81 | 105 | $2,940 | $1,406 | 47.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 19 | 19 | $1,580 | $1,236 | 78.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 73 | 97 | $2,231 | $1,024 | 45.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 146 | 239 | $2,390 | $717.00 | 30.0% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 43 | 65 | $1,365 | $631.15 | 46.2% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2021 | 28 | 28 | $1,232 | $540.68 | 43.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 23 | 23 | $437.00 | $371.61 | 85.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 16 | 16 | $576.00 | $268.80 | 46.7% |
| 82043 | Urine microalbumin (protein) level | Office | 2021 | 30 | 45 | $630.00 | $260.10 | 41.3% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2021 | 29 | 43 | $395.00 | $222.74 | 56.4% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2021 | 12 | 12 | $468.00 | $220.68 | 47.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 20 | 23 | $332.00 | $178.71 | 53.8% |
| 84480 | Thyroid hormone, t3 measurement, total | Office | 2021 | 11 | 12 | $324.00 | $170.16 | 52.5% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2021 | 13 | 14 | $266.00 | $126.28 | 47.5% |
About Dr. Richard Sharp, M.D
Dr. Richard Sharp, M.D is a Family Medicine healthcare provider based in Lehi, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508817453.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Sharp, M.D has received a total of $879.34 in payments from pharmaceutical and medical device companies, with $97.24 received in 2024. These payments were reported across 52 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($879.34).
As a Medicare-enrolled provider, Sharp has provided services to 3,482 Medicare beneficiaries, totaling 4,669 services with total Medicare billing of $154,074. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Lehi, UT
- Active Since 05/15/2006
- Last Updated 11/27/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1508817453
Products in Payments
- VYVANSE (Drug) $185.17
- VRAYLAR (Drug) $161.18
- MYDAYIS (Drug) $97.69
- CONTRAVE (Drug) $32.74
- AFFINITY (Medical Supply) $30.88
- ADDYI (Drug) $24.94
- PENTACEL (Drug) $21.51
- PREVNAR 20 (Biological) $19.09
- Otezla (Drug) $18.40
- WaveWriter Alpha Prime 16 (Device) $18.20
- Vascepa (Drug) $17.53
- Evzio (Drug) $17.50
- JARDIANCE (Drug) $17.42
- Horizant (Drug) $17.28
- SEGLENTIS (Drug) $16.79
- STIOLTO RESPIMAT (Drug) $16.32
- NAPRELAN (Drug) $16.02
- LILETTA (Drug) $15.74
- XIFAXAN (Drug) $15.30
- FREESTYLE LIBRE 2 (Device) $15.12
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lehi
Toran Macarthur, M.d, M.D
Family Medicine — Payments: $12,446
Dr. Tauaina Ngatuvai, M.d, M.D
Family Medicine — Payments: $12,080
Cheryl Johnson, M.d, M.D
Family Medicine — Payments: $11,288
Shawn Mcmanus, Do, DO
Family Medicine — Payments: $6,001
David Kimball, D.o., D.c, D.O., D.C
Family Medicine — Payments: $2,841
Dianne Farley Jones, Md, MD
Family Medicine — Payments: $769.67